Unraveling the origins of human adeno-associated virus 5
Robert J Gifford, Robert M Kotin
Opportunities to implement continuous processing in production of recombinant adeno-associated viral vectors
G Thakur, S Mink, H Bak et al
Therapeutic mRNA delivery with targeted lipid nanoparticles: next-generation transformative medicines
Umar Iqbal, Jagdeep K Sandhu
Enabling development of commercial-ready lentiviral vector manufacturing processes using stable producer cell lines
Peter Archibald, Ph.D, Anthony Shillings
22 September 2021
Commentary
Considerations for performing virtual quality audits on manufacturers of gene therapy viral vectors: an auditor’s perspective during the COVID-19 public health emergency
Gary C du Moulin, PhD, MPH, RAC
Tools for tomorrow: expression without cells
Jade Tuck, Stuart Jamieson, Philip Probert
08 January 2021
Commentary
Two new capture options for improved purification of large mRNA
P Gagnon, B Goričar, Š Peršič et al
01 September 2020
Commentary
Analytical Technology Used in the Latest Development of Gene Therapy Candidates
Z Li, Z Wu, T Maekawa et al